CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Cantor Fitzgerald Upgrades Capricor Therapeutics to Overweight From Neutral, Adjusts PT to $28 From $3.50

Positive
AI Analysis

Summary

Cantor Fitzgerald upgraded Capricor Therapeutics to Overweight from Neutral and raised price target to $28 from $3.50.

Importance:3/10
Sentiment:
0.80
analyst_upgradeprice_target_increaseequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 14, 2026 11:30 AM

Read Original